Skip to main content


EDM (Early Day Motion) 497: tabled on 12 October 2015

Tabled in the 2015-16 session.

This motion has been signed by 25 Members. It has not yet had any amendments submitted.

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Motion text

That this House notes that medicinal herbal cannabis is used successfully for the relief of pain, and muscle spasms associated with multiple sclerosis and spinal cord damage, for those not helped by other medications, chronic neuropathic pain, for example caused by a damaged nerve, facial neuralgia, chronic pain following shingles, and weight loss and debilitation due to cancer and AIDs; further notes it is also effective in relieving nausea and vomiting associated with chemotherapy or radiotherapy when other treatments fail, also extreme epilepsy in children, and therapy-resistant glaucoma; notes that herbal cannabis is used for medical purposes in Germany, Switzerland, the Netherlands, Israel, Spain, Canada and more than 20 US states; and calls on the Government to reschedule cannabis from schedule 1 to schedule 2 which would recognise its medicinal value and enable GPs to prescribe much cheaper cannabis medicines than Sativex which is extremely expensive.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.